Distinct effects of thrombopoietin depending on a threshold level of activated Mpl in BaF-3 cells

Journal of Cell Science

Volumn 115, Issue 11, 2002, Pages 2329-2337

  Millot, Gaél A ^a   Vainchenker, William ^a   Duménil, Duménil ^a   Svinarchuk, Fédor ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Mpl; Proliferation; Signaling pathways; Survival; Threshold activation level

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN BAD; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN P44; RECOMBINANT THROMBOPOIETIN; BAD PROTEIN, MOUSE; CARRIER PROTEIN; CYTOKINE RECEPTOR; DNA BINDING PROTEIN; ENZYME INHIBITOR; MILK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MPL PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; STAT5 PROTEIN; THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR; TRANSACTIVATOR PROTEIN; TUMOR PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DENSITY; CELL PROLIFERATION; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; CELL CLONE; CELL DIVISION; CELL MEMBRANE; CYTOLOGY; DRUG EFFECT; EUKARYOTIC CELL; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMAL; APOPTOSIS; CARRIER PROTEINS; CELL DIVISION; CELL MEMBRANE; CELL SURVIVAL; CLONE CELLS; DNA-BINDING PROTEINS; ENZYME INHIBITORS; EUKARYOTIC CELLS; GENE EXPRESSION; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; THROMBOPOIETIN; TRANS-ACTIVATORS; ANIMALS; BCL-ASSOCIATED DEATH PROTEIN; MILK PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, THROMBOPOIETIN; STAT5 TRANSCRIPTION FACTOR;

EID: 0036591964     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl
2. The catalytic subunit of phosphoinositide 3-kinase: Requirements for oncogenicity
3. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: Key role of thrombopoietin
4. Immunoaffinity purification of FLAG epitope-tagged bacterial alkaline phosphatase using a novel monoclonal antibody and peptide elution
5. Phosphoinositide 3-kinase-dependent regulation of IL-3-induced proliferation: Involvement of mitogen-activated protein kinases, SHP2 and Gab2
6. The Mp1 receptor is expressed in the megakaryocytic lineage from late progenitors to platelets
7. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors
8. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
9. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand
10. The thrombopoietin receptor can mediate proliferation without activation of the Jak-STAT pathway
11. The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc and c-Mpl
12. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line
13. Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors
14. Phosphatidylinositol 3-kinase is necessary but not sufficient for thrombopoietin-induced proliferation in engineered Mpl-bearing cell lines as well as in primary megakaryocytic progenitors
15. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation
16. Thrombocytopenia in c-mpl-deficient mice
17. Thrombopoietin, a direct stimulator of viability and multilineage growth of primitive bone marrow progenitor cells
18. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development
19. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice
20. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo
21. Stromal-derived factor 1 and thrombopoietin regulate distinct aspects of human megakaryopoiesis
22. Transformation of mammalian cells by constitutively active MAP kinase kinase
23. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line
24. Thrombopoietin promotes the survival of murine hematopoietic long-term reconstituting cells: Comparison with the effects of FLT3/FLK-2 ligand and interleukin-6
25. IL-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo
26. Murine interleukin 7 (IL-7) receptor. Characterization on an IL-7-dependent cell line
27. IGFs stimulate zebrafish cell proliferation by activating MAP kinase and PI3-kinase-signaling pathways
28. Thrombopoietin directly and potently stimulates multilineage growth and progenitor cell expansion from primitive (CD34+ CD38-) human bone marrow for c-kit and flt3, and inhibitory effects of TGF-beta and TNF-alpha
29. Thrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: Distinct interactions with the ligands for c-kit and FLT3
30. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: Role in endomitosis
31. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line
32. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway
33. Thrombopoietin induces activation of the phosphatidylinositol-3′ kinase pathway and formation of a complex containing p85PI3K and the protooncoprotein p120CBL
34. Overexpression of mitogen-activated protein kinase kinase (MAPKK) and its mutants in NIH 3T3 cells. Evidence that MAPKK involvement in cellular residues in its kinase subdomains VII and VIII
35. Role of c-mpl in early hematopoiesis
36. cMpl ligand is a humoral regulator of megakaryocytopoiesis
37. A ligand-receptor signaling threshold model of stem cell differentiation control: A biologically conserved mechanism applicable to hematopoiesis
38. Proliferation of CECs requires dual signaling through both MAPK/ERK and PI 3-K/Akt pathways